An Observational Study to Assess the Utilisation and Safety of Ixekizumab Among Pediatric Patients Treated in the Course of Routine Clinical Care (I1F-MC-B015)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Assessment of risk minimisation measure implementation or effectiveness

  Drug utilisation

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  IXEKIZUMAB
• Medical condition to be studied:
  Psoriasis

Population studied

• Age groups:
  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)
• Estimated number of subjects:
  400

Study design details

• Main study objective:
  To monitor the uptake of ixekizumab in a real-world pediatric population To characterize the demographics and clinical characteristics of pediatric patients receiving ixekizumab To provide additional information about the long-term safety pertaining to serious infections and inflammatory bowel disease
• Outcomes:
  Demographic and clinical characteristics of pediatric patients receiving ixekizumab, Long-term safety pertaining to serious infections and inflammatory bowel disease in pediatric patients receiving ixekizumab
• Data analysis plan:
  TBD